Bruce Bigelow, editor at Xconomy, writes:
San Diego’s Epic Sciences said today it has signed an agreement with LabCorp (NYSE: LH) to help speed up European clinical trials that are using Epic’s technology to identify tumor cells in the blood.
LabCorp, the Burlington, NC, company officially known as Laboratory Corporation of America, operates one of the world’s largest networks of medical laboratories for testing clinical samples. Under their agreement, LabCorp’s central lab in Belgium will pre-process blood samples from clinical trials throughout Europe and send prepared slides to Epic’s certified lab in La Jolla.